Ke Li

13PUBLICATIONS
54CO-AUTHORS
Molecular targetsChemical and thermal processes in energy and combustionHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 30, 2026
A Novel Peptide Targeting the USP25-SIRT1 Interaction Activates SIRT1 to Suppress Cell Senescence.

|Jan 13, 2026
GCN5-ERK lactylation-phosphorylation loop amplifies lactate-driven cancer progression.

Bingsong Huang, Mingpeng Jin, Gaofeng Cui

|Sep 02, 2025
Targeting HDAC8 sensitizes tyrosine kinase inhibitors in the elimination of B-cell acute lymphoblastic leukemia cells through degradation of HIF-1α.

Guilin Xu, Feng Wang, Ming Chen

|Aug 12, 2025
Cathepsin D promotes acute myeloid leukemia progression through stabilization of the anti-apoptotic proteins.

Huimin Jiang, Yongjian Wang, Churan Wang

|Jan 13, 2025
Oncogenic role of RARG rearrangements in acute myeloid leukemia resembling acute promyelocytic leukemia.

Feng Wang, Luyao Zhao, Yun Tan

|Aug 28, 2024
Activation and antitumor immunity of CD8+ T cells are supported by the glucose transporter GLUT10 and disrupted by lactic acid.

Ying Liu, Feng Wang, Dongxue Peng

Pageof 3

Frequent Collaborators

5 joint publications

Jian Yuan

3 joint publications

Tingting Zhang

3 joint publications

Xiaowei Zhang

2 joint publications

Hong-Hu Zhu